149 – Time-to-Rebound Measurements in ATI Trials With bNAb Intervention Are Confounded by Autologous NAbs
Background Many HIV cure trials use time-to-rebound during an analytic treatment interruption (ATI) as a primary outcome measurement. In a previously described ATI study with no intervention, the fraction of replication-competent outgrowth viruses neutralized by contemporaneous autologous neutralizing antibodies (aNAbs) prior to ART interruption correlated with time to rebound. Therefore, aNAbs may also contribute to…